| Phase 4 |
| NCT07612774 |
CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS |
Coronary |
Recruiting |
| Phase 3 |
| NCT06627712 |
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC |
TNBC - Triple-Negative Breast Cancer |
Recruiting |
| NCT07467083 |
Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for… |
Head and Neck Cancer |
Recruiting |
| NCT06663956 |
A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management |
Cancer Pain |
Recruiting |
| NCT07336953 |
A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus… |
PDAC - Pancreatic Ductal Adenocarcinoma |
Not Yet Recruiting |
| NCT07593846 |
The Comparison Between DEDTI BR and T/E BR |
Breast Cancer |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06798363 |
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of… |
Infantile Hemangioma |
Recruiting |
| NCT07353671 |
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis |
Radiation-induced Dermatitis |
Recruiting |
| NCT07608224 |
HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable… |
Urinary Bladder Neoplasms |
Not Yet Recruiting |
| Phase 2 |
| NCT06859684 |
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in… |
Intrahepatic Cholangiocarcinoma (Icc) |
Recruiting |
| NCT07282483 |
Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral… |
Radiation-induced Oral Mucositis |
Recruiting |
| NCT07339774 |
Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis… |
Radiotherapy-induced Oral Mucositis |
Recruiting |
| NCT07040956 |
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT07572864 |
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06132698 |
Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal… |
NSCLC Associated With Leptomeningeal Metastases |
Recruiting |
| NCT07492914 |
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous… |
Resectable Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT07324018 |
Spirulina Derivative for Radiation Esophagitis |
Radiation-induced Esophagitis |
Not Yet Recruiting |
| NCT07381075 |
A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or… |
Head and Neck Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT07398664 |
H101 Plus TACE for r/m HNSCC |
Head and Neck Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT07381699 |
MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A… |
Nasopharyngeal Cancinoma (NPC) |
Not Yet Recruiting |
| NCT07472933 |
Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract… |
Cancer of Biliary Duct |
Not Yet Recruiting |
| NCT07040969 |
Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy… |
Radiation-induced Oral Mucositis |
Active, Not Recruiting |
| NCT07635290 |
Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer |
Previously Treated, Advanced |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07182565 |
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of… |
Gastroesophageal Junction Adenocarcinoma |
Recruiting |
| NCT07035249 |
DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors |
DCSZ11 |
Recruiting |